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Abstract: The genus Aesculus L. (Hippocastanaceae) has 12 species distributed in eastern Asia, eastern and western 
North America, and Europe. In Europe and the United States, A. hippocastanum has been used for the treatment of 
chronic venous insufficiency, hemorrhoids, and postoperative edema. In China, A. chinensis var. chinense has been used 
as a stomachic and analgesic in the treatment of distention and pain in the chest and the abdomen, malaria, dysentery, and 
heart disease. The objective of this paper is to review the ethnobotany, phytochemistry, and pharmacological properties of 
the genus Aesculus. To date, more than 210 compounds have been isolated and identified primarily from the fruits or 
seeds of Aesculus, with polyhydroxylated triterpenoid saponins as the major active principles. Studies have confirmed that 
Aesculus seed extracts and isolates possess diverse activities, including anti-inflammatory, antitumor, antiviral, antifungal, 
antiangiogenic (vascular protection), anti-obesity, antioxidative, and antigenotoxic properties. Interestingly, detailed stud-
ies of the saponins from more eastern North American species and other uninvestigated Aesculus species are necessary to 
further confirm the chemotaxonomic value of the novel cytotoxic saponins discovered recently from A. pavia, an eastern 
North American species, and to fully understand the chemical profile of the genus. Animal investigations of these novel 
cytotoxic saponins on the potential for the treatment of cancer are also intriguing. 
Keywords: Aesculus; horse chestnut; buckeyes; ethnobotany; phytochemistry; triterpenoid saponins; bioactivities; anti-tumor 
activity. 
INTRODUCTION 
Aesculus L. is a genus of the family Hippocastanaceae 
containing 12 species of deciduous trees and shrubs in the 
northern hemisphere, primarily in eastern Asia and eastern 
North America, with one species native to Europe, and two 
to western North America [1-4]. Aesculus have been culti-
vated as pharmaceutical crops for the production of Stan-
dardized Therapeutic Extracts (STEs). There are two Eura-
sian species commonly used in medicine: A. hippocastanum 
(common horse chestnut) and A. chinensis var. chinensis 
(Chinese horse chestnut). In Europe, the bark, leaves, horse 
chestnut seed extract (HCSE), and aescin (a saponin mix-
ture) from A. hippocastanum have been used in the treatment 
of chronic venous insufficiency, hemorrhoids, and postop-
erative edema [5-9]. In China, the seeds of A. chinensis var. 
chinensis have been used as a stomachic and analgesic in the 
treatment of distention and pain in chest and abdomen, ma-
laria, and dysentery [10] and tablets made from the seeds are 
also used for treating heart diseases [11]. Modern pharma-
cologic investigations have confirmed that HCSE, aescin and 
individual compounds isolated and identified from the two 
Eurasian species and other Aesculus species possess diverse 
activities, including anti-inflammatory, antitumor, antiviral,  
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antioxidative, and antigenotoxic properties. The chemical 
constituents of some Aesculus species have been well docu-
mented. To date, more than 210 compounds from different 
classes have been isolated and identified from the genus 
Aesculus. These compounds include triterpenoids, triterpe-
noid glycosides (saponins), flavonoids, coumarins, caro-
tenoids, long fatty chain compounds, and some other classes 
of compounds. The present paper with 108 references reviews 
the research advances in the enthnobotany, phytochemistry 
and phamarcological activities of the genus Aesculus. 
BOTANY, CULTIVATION, AND MEDICAL USES  
To date, over a hundred species or varieties in Aesculus 
have been described because of great morphological varia-
tions due to natural pollination among the species. In his 
monograph of Aesculus, Koch (1857) recognized 13 species 
in four subgenera, Hippocastanum, Pavia, Calothyrsus, and 
Macrothyrsus [12]. Based on bud viscidity, fruit exocarp 
ornamentation, flower color, and petal morphology, the 13 
species were grouped into five sections [1, 2, 13]. All new 
species discovered in the last several decades are not recog-
nized and thus most authors recognized 13 species in the 
genus until A. wilsonii Rehder was recently treated as a vari-
ety under the species A. chinensis Bunge [3, 14]. The 12 
currently recognized species in the genus Asculus are 
grouped in the five sections: Section Aesculus in Europe and 
Japan (A. hippocastanum L. and A. turbinata Blume), Sec-
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tion Calothyrsus (Spach) K. Koch in Southeastern Asia and 
western United States (A. assamica Griffith, A. californica 
(Spach) Nutall, A. chinensis Bunge var. chinensis, A. chinen-
sis Bunge var. wilsonii ((Rehder) Turland & N.H. Xia, and 
A. indica (Camb.) Hook.), Section Pavia (Mill.) Persoon in 
the southeastern United States (A. glabra Willd. var. glabra, 
A. glabra Willd. var. arguta (Buckl.) Robinson, A. flava 
Sol., A. pavia L., and A. sylvatica Bartram), Section Mac-
rothyrsus (Spach) K. Koch in the southeastern United States 
(A. parviflora Walter), and Section Parryanae Wiggins in 
Baja California, Mexico (A. parryi A. Gray) (Table 1).  
The recent phylogenetic analysis of Aesculus by DNA 
sequences of chloroplast gene matK and internal transcribed 
spacers of nuclear ribosomal RNA genes supported Hardin's 
classification except for section Calothyrsus [4]. Some che-
motaxonomical analysis has been conducted [15]. Interest-
ingly, A. pavia in the Section Pavia has tritepernoid saponins 
with an oligosaccharide chain at C-3 of the aglycone with an 
α-arabinofuranosyl unit affixed to C-3 of the glucuronic acid 
while Eurasian species in Section Aesculus and Section Ca-
lothyrsus have saponins with a trisaccharide chain at C-3 of 
the aglycone with a β-glucopyranosyl unit attached to C-4 of 
the glucuronic acid [16] (see Triterpenoid Saponins for de-
tails). This significant chemical difference suggests that 
triterpenoid saponins may provide important clues in under-
standing the systematics and evolution of the genus Aescu-
lus.   
Aesculus are deciduous trees or shrubs with easily 
recognizable palmately compound leaves (5-11 leaflets), 
characteristic capsules and seeds, and attractive ornamental 
flowers. Aesculus hippocastanum has been cultivated since 
1576 as an ornamental plant [17] while A. chinensis var. 
chinensis has been planted in temples and homes for several 
centuries. At present, all species are cultivated, with at least 
27 commercial cultivars supplied by at least 95 nurseries in 
the United States [17].  Most species are propagated from 
seeds and the cultivars by budding or grafting. In Europe, 
HCSE and aescin are major pharmaceutical products from 
Aesculus.  
Aesculus hippocastanum is a large deciduous tree, also 
known as Conker tree. This species is native to a small area 
in the mountains of the Balkans in southeast Europe, in small 
areas in northern Greece, Albania, the Republic of 
Macedonia, Serbia, and Bulgaria. It is now widely cultivated 
throughout the temperate world because of its large, beauti-
ful flower clusters and its excellent resistance to environ-
mental conditions. The leaves of this species are opposite 
and palmately compound with 5-7 leaflets. The sessile leaf-
lets are green beneath with obtusely double-serrate. Its flow-
ers are usually white with a small red spot. The fruit is a 
green, spiky capsule containing one (rarely two or three) 
brown seed, called chestnut or conker [2].  
The common name "horse chestnut″may have come from 
the uses of seeds for horses to treat overexertion or coughs 
by Turks and Greeks [18]. Dated from the early 18th century, 
the horse chestnut has a therapeutic property for anti-fever 
[5]. In Europe, the bark and leaves of A. hippocastanum have 
been employed as an astringent to treat diarrhea and hemor-
rhoids [6]. The HCSE from A. hippocastanum has been used 
in the treatment of chronic venous insufficiency, hemor-
rhoids, and postoperative edema [7-9]. Aescin, also known 
as β-escin, is the major active component in HCSE and has 
been shown to have a clinically significant activity in 
chronic venous insufficiency, hemorrhoids, and post-
operative edema. The pharmacology, pharmacokinetics and 
therapeutic profile of aescin have been reviewed [5]. Based 
on the publication over the last two decades of numerous 
randomized controlled trials in prominent, peer-reviewed 
journals, A. hippocastanum extract is gaining wider accep-
tance as an effective therapy for venous disorders and edema 
in the United States [5]. 
Aesculus chinensis is native to China and is distributed 
mainly in the Hebei, Henan, and Shanxi provinces. The fruits 
of this species usually are smooth subglobose, truncate to 
slightly impressed at the apex, thickly walled with smaller 
seeds having proportionately larger hilum. The surface of its 
petiolulate leaflets is glabrous or sparingly pilose [2].  Its 
seeds, called "Sha Luo Zhi" in traditional Chinese medicine, 
have long been used as a stomachic and analgesic in the 
treatment of distention and pain in chest and abdomen, ma-
laria, and dysentery [10]. Additionally, the tablets made from 
the seeds are used for treating heart diseases [11]. 
Aesculus turbinata, known as Japanese horse chestnut, is 
native only to Japan. It has been found on the island of Hok-
kaido and the central and northern parts of Honshu. This 
species has been widely cultured in England, the United 
States, and China. This species is similar to A. hippocasta-
num, differently mainly in the slightly smaller flowers, warty 
fruit surface, and in the larger leaves, which are glaucescent 
beneath and have more regularly crenate-serrate margins [2]. 
The seeds of the Japanese horse chestnut have been used as 
an emergency provision since ancient times and utilized tra-
ditionally in Japan as a confectionery ingredient in rice cakes 
and rice balls [19]. Its seed extract in combination with spir-
its have also been used as a folk medicine for the treatment 
of bruises and sprains in some regions of Japan [20]. 
Aesculus indica, known as Indian horse chestnut, is 
found on mountain slopes or in moist and shady valleys in 
the northwestern Himalayan forests. It is distributed from 
Nepal northwestward into the State of Kashmir in north In-
dia, and across the Indus River to West Pakistan and to 
northeastern Afghanistan. Its fruits are reddish brown, 
smooth ovoids. The petiolulate leaflets of this species are 
submembranacous with finely serrate margin [2]. In some 
parts of Himachal Pradesh, the seeds are dried and grounded 
into flour, called tattwakhar. This flour is bitter and used for 
making halwa, which is taken as phalahar (non-cereal food) 
during fasts; the leaves are used as a fodder for cattle. India 
horse chestnut also has medicinal properties for animals and 
human beings. The fruits are given to horses suffering from 
colic. The oil extracted from the seeds is used to cure rheu-
matism [21]. 
Seeds of North American species (e.g., A. pavia, A. flava, 
A. glabra, and A. californica), known as buckeyes, were 
used by Native Americans to tranquilize fish to make them 
easier to catch [22]. Extracts from the seeds were used to 
treat earaches, sores, colic, sprains, and chest pains [23]. 
Powdered bark was sometimes used to alleviate toothaches 
and ulcer pain [24]. 
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Table 1. Species List of Aesculus L 
Taxa Synonyms 
Distribution (Native 
Range) 
References for Chemi-
cal Studies 
Sect. Aesculus  Europe, Japan  
A. hippocastanum L. A. asplenifolia Loud.  
A. castanea Gilib.  
A. heterophylla Hort. ex Handl.  
A. ohiotensis Lindl. 
A. hippocastanum f. beaumanii (C.K.Schneid.) Dole 
A. hippocastanum f. laciniata (Jacq.) Schelle  
A. hippocastanum f. pendula (Puvill.) Rehder  
A. hippocastanum f. pyramidalis Henry  
A. hippocastanum var. argenteovariegata Loudon 
A. hippocastanum var. aureovariegata Loudon 
A. hippocastanum var. asplenifolia Hort.  
A. hippocastanum var. beaumanii Schneid.  
A. hippocastanum var. dissecta Hort.  
A. hippocastanum var. flore-pleno Loudon 
A. hippocastanum var. incisa Booth ex Loud.  
A. hippocastanum var. laciniata Jacq.  
A. hippocastanum var. pendula Puvill.  
A. hippocastanum var. pumila Dipp.  
A. hippocastanum var. umbraculifera Jaeg.  
A. hippocastanum var. variegata Loudon  
A. incisa hort. ex Handl.   
A. memmingeri C.Koch  
A. procera Salisb.  
A. septenata Stokes  
Esculus hipocastanea (L.) Rafinesque 
Hippocastanum aesculus Cav. 
Hippocastanum vulgare Gaertner  
Pawia hippocastanum (L.) Kuntze 
S. Albania Bulgaria, N. 
Greece, former Yugo-
slavia  
25, 26, 27, 28, 35, 36, 
37, 38, 39, 40, 64, 65, 
69, 70, 73, 75, 76 
A. turbinata Blume A. dissimilis Blume  
A. sinensis Hort. 
A. turbinata var. pubescens Rehder 
A. turbinata f. pubescens (Rehder) Ohwi ex Yas 
Pawia dissimilis (Blume) Kuntze 
Pawia turbinata (Blume) Kuntze 
Japan 19, 20, 41, 42, 43, 44, 
45, 71, 72, 74  
Sect. Calothyrsus (Spach) K. Koch  SE Asia, W. USA  
A. assamica Griffith A. chuniana Hu & W.P. Fang 
A. coriaceifolia Hu & W.P. Fang* 
A. khassayana C.R. Das & Majumdar.* 
A. lantsangensis Hu & W.P. Fang 
A. megaphylla Hu & W.P. Fang 
A. polyneura var. dongchusnensis Li & Yin 
A. punduana Wallich ex Hiern 
A. rupicola Hu & W.P. Fang 
A. tsiangii Hu & W.P. Fang* 
A. wangii Hu* 
A. wangii var. rupicola (Hu & W.P. Fang) W.P. Fang* 
Pavia khassayana Viogt. 
SW China, Bangladesh, 
Bhutan, NE India, 
Laos, Myanmar, Thai-
land, N. Vietnam 
32, 33, 54, 55, 56, 57 
A. californica (Spach) Nutall Calothyrsus californica Spach 
Hippocastanum californicum Greene 
Pavia californica (Spach) Hartweg 
Pawia californica Kuntze 
California, USA 68, 82 
A. chinensis Bunge   China  
var. chinensis A. chekiangensis Hu & W.P. Fang 
A. chinensis var. chekiangensis (Hu & W.P. Fang) W.P. Fang 
Central China 46, 47, 48, 45, 50, 52, 
53, 66 
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Table 1. contd…. 
Taxa Synonyms 
Distribution (Native 
Range) 
References for Chemi-
cal Studies 
var. wilsonii (Rehder) 
Turland & N.H. Xia 
A. wilsonii Rehder 
Actinotinus sinensis Oliver  
Central and SW China 32, 33, 34, 79, 83 
A. indica (Camb.) Hook. A. indica var. concolor Browicz  
Pavia indica Wall. ex Cambess 
Himalayas 29, 58, 59, 60, 62, 63, 
76, 77, 78 
Sect. Pavia (Mill.) Persoon  SE USA  
A. glabra Willd.     
var. glabra A. ohioensis De Candolle 
Nebropsis glabra (Willd.) Rafinesque 
Pavia glabra (Willd.) Spach 
Pawia glabra (Willd.) Kuntze 
 31 
var. arguta (Buckl). Robinson A. arguta Buckl.   
A. flava Sol. A. flava Aiton  
A. flava f. vestita (Sargent) Fernald 
A. flava var. virginica (Sargent) Fernald 
A. flava var. purpurascens A. Gray 
A. flava var. purpurea Hort 
A. flava var. rosea Hort 
A. flava var. sanguinea Hort 
A. lutea Wangh. 
A. maxima D. Drake 
A. octandra Mrshall 
A. octandra f. vestita (Sargent) Fernald  
A. octandra f. virginica (Sargent) Fernald  
A. octandra var. purpurascens (A.Gray) C.K.Schneid  
A. octandra var. vestita Sargent  
A. octandra var. virginica Sargent 
Pavia bicolor Rafinesque 
P. flava (Sol.) Moench 
P. fulva Rafinesque 
P. lutea Poir. 
Pavia reticulata Rafinesque  
Paviana flava (Sol.) Rafinesque  
Pawia octandra (Marshall) Kuntze 
P. octandra var. flava (Sol.) Kuntze 
  
A. pavia L. A. austrina Small 
A. dicolor Pursh 
A. florida Bartram 
A. humilis Loddiges ex Lindley 
A. octandra var. discolor (Pursch) Rehder 
A. pavia var. atrosanguinea Kirchner 
A. pavia var. discolor (Pursh) Torrey & A. Gray 
A. pavia var. nana Dippel 
A. pavia var. pendula (Loudon) Rehder  
A. pavia var. whitleyi Rehder 
A. splendens Sargent 
 16, 30, 61, 67, 74, 75 
A. pavia L. (continued) Pavia americana Saint-Hilaire 
P. atropurpurea Spach 
P. glauca Rafinesque 
P. humilis (Loddiges ex Lindley) G. Don ex Loudon 
P. intermedia Spach 
P. lindleyana Spach 
P. livida Spach 
P. longiflora Rafinesque 
P. lucida Spach 
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Table 1. contd…. 
Taxa Synonyms 
Distribution (Native 
Range) 
References for Chemi-
cal Studies 
 P. michauxii Spach 
P. mollis Rafinesque 
P. octandra Miller 
P. parviflora Rafinesque 
P. punctata Rafinesque 
P. rubra Lamarck 
P. versicolor Spach 
P. willdenowiana Spach 
  
A. sylvatica Bartram A. georgiana Sargent 
A. georgiana var. lanceolata Sargent 
A. georgiana var. pubescens Sargent  
A. neglecta var. georgiana Sargent 
A. neglecta var. lanceolata Sargent 
A. neglecta var. tomentosa Sargent 
A. sylvatica var. lanceolata (Sargent) Bartr.  
  
Sect. Macrothyrsus (Spach) K.  
Koch 
 SE USA  
A. parviflora Walter A. alba (Poir.) Rafinesque 
A. macrostachya Michx.  
A. macrostachys Pers.  
A. odorata F. Dietr.  
A. parviflora f. serotina Rehder  
Macrothyrsus discolor Spach  
M. odorata (F. Dietr.) Rafinesque 
Nebropsis alba (Poir.) Rafinesque  
Pavia alba Poir.  
P. edulis Poit. ex DC.  
P. macrostachya (Michx.) DC.  
P. macrostachys (Pers.) Loisel.  
P. parviflora (Walter) Rafinesque 
Pawia parviflora (Walter) Kuntze 
SE USA 74, 80, 81 
Sect. Parryanae Wiggins  Baja California, Mexico  
A. parryi A. Gray Pawia parryi (A.Gray) Kuntze   
Note: * The taxon was not validly published.  
 
PHYTOCHEMISTRY  
Seeds of Aesculus are the plant materials often used for 
medicine in Eurasia and North America, and thus the seeds 
and fruits are the main targets for chemical investigations in 
the last several decades. To date, more than 210 compounds 
have been isolated and identified from Aesculus. These com-
pounds include triterpenoids, triterpenoid glycosides (sapon-
ins), flavonoids, coumarins, carotenoids, long fatty chain 
compounds, and some other classes of compounds. 
Triterpenoids 
Triterpenoids from the genus Aesculus belong to penta-
cyclic triterpenoids and have multiple hydroxyl groups at C-
3, C-15, C-16, C-21, C-22, C-24, and C-28. Their structures 
vary based on the substituents of hydroxyl at C-15 and C-24 
as well as the number and type of acyl groups at C-16, C-21, 
C-22, and C-28. To date, six triterpenoids (1-6) and 14 acyl-
triterpenoids (7−20) (Table 2) have been isolated and identi-
fied from the hydrolysate of the saponin mixtures extracted 
from the seeds of Aesculus. Aescigenin (1), a product of the 
acid hydrolysis of the saponin aescin from the seeds of A. 
hippocastanum, was the first triterpenoid reported [25]. 
Later, a number of triterpenoids (sapogenins) and acyl-
triterpenoids (prosapogenins) were isolated and identified 
from the acid and alkaline hydrolysates of the Aesculus 
saponin mixtures. These hydrolytic products include barring-
togenol-D (2) [26], R1-barrigenol (4) [27], barringtogenol-C 
(6) [27], 21-O-tigloyl-22-O-angeloyl-R1-barrigenol (10) [27], 
16-O-acetylprotoaescigenin (12) [28], 21-O-angeloylproto- 
aescigenin (13) [28], 28-O-angeloylprotoaescigenin (15) 
[28], and 21-O-angeloylbarringtogenol-C (18) [27] from A. 
hippocastanum; aescigenin (1), protoaescigenin (5), barring- 
togenol-C (6), 22-angeloyl-R1-barrigenol (9), 21-angeloyl- 
barringtogenol-C (18), 21,22-diangeleylbarrintogenol-C (20) 
from A. indica [29]; 24-hydroxy- R1-barrigenol (3) [16], R1-
barrigenol (4) [16], barringtogenol-C (6) [30], 21-O-ange- 
loyl-24-hydroxy-R1-barrigenol (7) [30], 21-O-angeloylpro- 
toaescigenin (13) [30], 22-O-angeloylprotoaescigenin (14) 
[30], 21, 22-O-diangeloylprotoaescigenin (16) [30], 21-O-
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1    R = OH
2    R = H
3
15
16
21
22
24
28
HO
OR6
OR4
OR3
OR2
R5
Ang: angeloyl Tig: tiggeloyl Ac: acetyl
OO O
OR1
HO
OH
OH
R
O
 
Number Name R1 R2 R3 R4 R5 R6 
3 24-Hydroxy-R1-barrigenol OH H H H OH H 
4 R1-barrigenol OH H H H H H 
5 Protoaescigenin H H H H OH H 
6 Barringtogenol-C H H H H H H 
7 21-O-angeloyl-24-hydroxy-R1-barrigenol OH H Ang H OH H 
8 21-O-angeloyl-R1-barrigenol OH H Ang H H H 
9 22-O-angeloyl-R1-barrigenol OH H H Ang H H 
10 21-O-tigloyl-22-O-angeloyl-R1-barrigenol OH H Tig Ang H H 
11 21, 22-O-diangeloyl-R1-barrigenol OH H Ang Ang H H 
12 16-O-acetylprotoaescigenin H Ac H H OH H 
13 21-O-angeloylprotoaescigenin H H Ang H OH H 
14 22-O-angeloylprotoaescigenin H H H Ang OH H 
15 28-O-angeloylprotoaescigenin H H H H OH Ang 
16 21, 22-O-diangeloylprotoaescigenin H H Ang Ang OH H 
17 21-O-tigloylbarringtogenol-C H H Tig H H H 
18 21-O-angeloylbarringtogenol-C H H Ang H H H 
19 28-O-tigloylbarringtogenol-C H H H H H Tig 
20 21, 22-O-diangeloylbarringtogenol-C H H Ang Ang H H 
 
Table 2. The Triterpenoids and Triterpenoid Saponins Reported in Various Taxa of Aesculus 
Sect. Aesculus Sect. Calothyrsus Sect. Pavia 
No. Name 
AHa ATa AAa ACa ACWa AIa AGa APa 
1 Aescigenin 25b    34 b 29 b   
2 Barringtogenol-D 26        
3 24-Hydroxy-R1-barrigenol        16 b 
4 R1-barrigenol 27       16 
5 Protoaescigenin   32 b  34 29   
6 Barringtogenol-C 27  33   29  30 
7 21-O-angeloyl-24-hydroxy-R1-barrigenol        30 
8 21-O-angeloyl-R1-barrigenol       31  
9 22-O-angeloyl-R1-barrigenol      29 31  
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Table 2. contd…. 
Sect. Aesculus Sect. Calothyrsus Sect. Pavia 
No. Name 
AHa ATa AAa ACa ACWa AIa AGa APa 
10 21-O-tigloyl-22-O-angeloyl-R1-barrigenol 27        
11 21, 22-O-diangeloyl-R1-barrigenol       31  
12 16-O-acetylprotoaescigenin 28        
13 21-O-angeloylprotoaescigenin 28  32  34   30 
14 22-O-angeloylprotoaescigenin        30 
15 28-O-angeloylprotoaescigenin 28        
16 21, 22-O-diangeloylprotoaescigenin        30 
17 21-O-tigloylbarringtogenol-C        30 
18 21-O-angeloylbarringtogenol-C 28     29 31 30 
19 28-O-tigloylbarringtogenol-C        30 
20 21, 22-O-diangeloylbarringtogenol-C      29 31  
21 Escin Ia 26, 38, 39 41  46 51, 52    
22 Escin Ib 35, 38, 39 41  46 51, 52    
23 Escin IIa 38, 39 42       
24 Escin IIb 38, 39 42       
25 Escin IIIa 38, 39    51    
26 Escin IIIb 40        
27 Escin IV 40        
28 Escin IVc  44  47 52    
29 Escin IVd    47 52    
30 Escin IVe    47 53    
31 Escin IVf    47     
32 Escin IVg    48     
33 Escin IVh    48 53    
34 Escin V 40        
35 Escin VI 40        
36 Escin VIb    48     
37 Deacetylescin Ia  43       
38 Deacetylescin Ib  43   53 58   
39 Deacetylescin IIa  43       
40 Deacetylescin IIb  43       
41 Desacylescin I  43  48     
42 Desacylescin II  43       
43 Isoescin Ia 40 44  46 51, 52    
44 Isoescin Ib 40 44 60 46 51, 52    
45 Isoescin IIa    49 51    
46 Isoescin IIb    49 51    
47 Isoescin IIIa    49 51    
48 Isoescin IIIb    49     
49 Isoescin V 40        
50 Isoescin VIa  45       
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Table 2. contd…. 
Sect. Aesculus Sect. Calothyrsus Sect. Pavia 
No. Name 
AHa ATa AAa ACa ACWa AIa AGa APa 
51 Isoescin VIIa  45b       
52 Isoescin VIIIa  45       
53 Aesculioside A    46 b     
54 Aesculioside B    46     
55 Aesculioside C    46     
56 Aesculioside D    46     
57       60 b   
58 Aesculiside A    50     
59 Aesculuside B      59   
60 Assamicin III   55      
61 Assamicin IV   55      
62 Assamicin VI   57      
63 Aesculioside E    46     
64 Aesculioside F    46     
65 Aesculioside G    46     
66 Aesculioside H    46     
67 Assamicin I   54      
68 Assamicin II   54      
69 Assamicin V   56      
70 Assamicin VII   57      
71 Assamicin VIII   57      
72 Aesculioside Ia        16, 61 b 
73 Aesculioside Ib        16, 61 
74 Aesculioside Ic        16, 61 
75 Aesculioside Id        16, 61 
76 Aesculioside Ie        16, 61 
77 Aesculioside IIa        16, 61 
78 Aesculioside IIb        16, 61 
79 Aesculioside IIc        16, 61 
80 Aesculioside IId        16, 61 
81 Aesculioside IIe        61 
82 Aesculioside IIf        61 
83 Aesculioside IIg        61 
84 Aesculioside IIh        61 
85 Aesculioside IIi        61 
86 Aesculioside IIj        61 
87 Aesculioside IIk        61 
88 Aesculioside IIIa        61 
89 Aesculioside IIIb        61 
90 Aesculioside IIIc        61 
91 Aesculioside IIId        61 
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Table 2. contd…. 
Sect. Aesculus Sect. Calothyrsus Sect. Pavia 
No. Name 
AHa ATa AAa ACa ACWa AIa AGa APa 
92 Aesculioside IIIe        61 
93 Aesculioside IIIf        61 
94 Xanifolia-Y        61 
95 Aesculioside IVa        16, 61 
96         16, 61 
97 Aesculioside IVb        16, 61 
98         16, 61 
99 Aesculioside IVc        16, 61 
a AH: A. hippocastanum, AT: A. turbinata; AA: A. assamica; AC: A. chinensis; ACW: A. chinensis var. wilsonii; AI: A. indica; AG: A. glabra, AP: A. pavia. b reference number.  
 
tigloylbarringtogenol-C (17) [30], 21-O-angeloylbarringto- 
genol-C (18) [30], and 28-O-tigloylbarringtogenol-C (19) [30] 
from A. pavia; 21-angeloyl-R1-barrigenol (8), 22-O-ange- 
loyl-R1-barrigenol (9), 21,22-O-diangeloyl-R1-barrigenol (11), 
21-O-angeloylbarringtogenol-C (18), and 21,22-O-diange- 
loylbarringtogenol-C (20) from A. glabra [31]; protoaesci-
genin (5) [32], barringtogenol-C (6) [33], and 21-O-angy- 
loylprotoescigenin (13) [32] from A. assamica; and aesci-
genin (1), protoaescigenin (5), and 21-O-angeloylproto- 
aescigenin (13) from A. chinensis var. wilsonii [34]. 
Triterpenoid Glycosides (Triterpenoid Saponins) 
Triterpenoid glycosides or saponins are one of the main 
groups of chemical constituents from Aesculus. They are 
classified as polyhydroxylated triterpenoid glycosides based 
on four different aglycones (sapogenins), including 24-
hydroxy-R1-barrigenol (3), R1-barrigenol (4), protoaesci-
genin (5), and barringtogenol-C (6), due to the different sub-
stituents of hydroxyl at C-15 and C-24. To date, about 79 
saponins have been isolated and identified from the genus 
Aesculus (Table 2). Most of the Aesculus saponins have a 
trisaccharide chain with a glucuronopyranosyl unit attached 
to the C-3 position of the aglycone. A few saponins have a 
disaccharide chain at C-3 of the sapogenin, such as assami-
cins V (69), VIII (71), aesculiosides Ie (76), and IId (80) 
while assamicins II (68), III (60), IV (61), and VI (62) are 
bisdesmosidic glycosides. The Aesculus type of saponins 
usually possesses acyl functions at C-21, C-22, and C-28 
positions, some rarely, at C-16, such as escin VIb (36). The 
acyl functions include angeloyl (Ang), tigloyl (Tig), acetyl 
(Ac), 2-methylbutanoyl (MB), and 2-methylpropanoyl (MP) 
groups.  
The isolation and the structural determination of the indi-
vidual ingredients in the saponin mixtures from the genus 
Aesculus have been the target of many investigations. The 
structures of two major saponins in aescin from the seeds of 
A. hippocastanum were first presumed as escins Ia (21) and 
Ib (22) on the basis of chemical and physicochemical evi-
dences obtained by using the saponin mixture [26, 35]. Then, 
the two major saponins were isolated from the commercial 
β-escin [36], and their MS data were reported based on the 
previous presumed structures [37]. The detailed phytochemi-
cal investigation of the saponins from A. hippocastanum was 
conducted by Yoshikawa's group [38-40].  A total of 12 
saponins were isolated from the seeds of this species. The 
structures of these saponins were determined by extensive 
NMR and HRMS analysis as well as chemical degradation. 
These saponins are escins Ia (21) [38, 39], Ib (22) [38, 39], 
IIa (23) [38, 39], IIb (24) [38, 39], IIIa (25) [38, 39], IIIb 
(26) [40], IV (27) [40], V (34) [40], and VI (35) [40] and 
isoescins Ia (43) [40], Ib (44) [40], and V (49) [40]. 
The seeds of A. turbinata also contain rich triterpenoid 
saponins as the main components. A number of investiga-
tions on the seeds of Japanese horse chestnut resulted in the 
isolation and structure determination of 16 polyhydroxylated 
triterpenoid saponins. These saponins are escins Ia (21) [41], 
Ib (22) [41], IIa (23) [42], and IIb (24) [42]; deacetylescins 
Ia (37), Ib (38), IIa (39), and IIb (40) [43]; desacylescins I 
(41) and II (42) [43]; escin IVc (28) [44]; isoescin Ia (43) 
[44], Ib (44) [44], VIa (50) [45], VIIa (51) [45], and VIIIa 
(52) [45]. 
Of the section Calothyrsus, A. chinensis var. chinensis 
has been well investigated. The triterpenoid saponins, occur-
ring as a complex mixture in the seeds of A. chinensis var. 
chinensis, had not been investigated until 1999, when two 
groups of researchers reported a number of novel saponins. 
The first group reported four pair of new geometrical isomer 
saponins from the plant, named aesculiosides A-H (53-56, 
63-66),  with two pair of known compounds, escins Ia (21), 
and Ib (22) and isoescins Ia (43) and Ib (44) [46]. The sec-
ond group reported four new saponins escins IVc (28), IVd 
(29), IVe (30), and IVf (31) [47]. The structures of these 
novel saponins were determined by extensive NMR, HRMS, 
and x-ray analyses, as well as chemical degradation. Later, 
from 2001 to 2004, more Aesculus polyhydroxylated triter-
penoid saponins were isolated and identified from the seeds 
of A. chinensis var. chinensis. These saponins include escins 
IVg (32), IVh (33), and VIb (36) [48]; desacylescin I (41) 
[48]; isoescins IIa (45), IIb (46), IIIa (47), and IIIb (48) [49]; 
and aesculiside A (58) [50]. Escins Ia (21), Ib (22), IIIa (25), 
isoescins Ia (43), Ib (44), IIa (45), IIb (46), and IIIa (47) 
were isolated and identified from A. chinensis var. wilsonii 
[51]. Aesculus chinensis Bunge var. chekiangensis (Hu & 
W.P. Fang) W.P. Fang was described based on cultivated 
plants and is now recognized as the synonym of A. chinensis 
var. wilsonii [14].  Its seeds, also called "Sha Luo Zhi" in 
An Overview of Genus Aesculus L. Pharmaceutical Crops, 2010, Volume 1   33 
O
OR5
OR3
OR2
OR1
R4
Ang: angeloyl
Tig: tiggeloyl
Ac: acetyl
O
O
OR6
OH
COOH
O
OH
OH
OH
HO
GlcA-p
Glc-p
O
OOH
OH
OH
HO
Gal-p
O
OH
OH
OH
Xyl-pO
O O OAng Tig Ac MP
MB
MP: 2-methylpropanoyl
MB: 2-methylbutanoyl
GlcA-p: !-D-glucuronopyranosyl acid
Glc-p: !-D-glucopyranosyl
Gal-p: !-D-galactopyranosyl
Xyl-p: !-D-xylopyranosyl
 
No. Name R1 R2 R3 R4 R5 R6 
21 Escin Ia H Tig Ac OH H Glc-p 
22 Escin Ib H Ang Ac OH H Glc-p 
23 Escin IIa H Tig Ac OH H Xyl-p 
24 Escin IIb H Ang Ac OH H Xyl-p 
25 Escin IIIa H Tig Ac H H Gal-p 
26 Escin IIIb H Ang Ac H H Gal-p 
27 Escin IV H Ac Ac OH H Glc-p 
28 Escin IVc H H Tig OH Ac Glc-p 
29 Escin IVd H H Ang OH Ac Glc-p 
30 Escin IVe H H H OH Tig Glc-p 
31 Escin IVf H H H OH Ang Glc-p 
32 Escin IVg H H Tig OH H Glc-p 
33 Escin IVh H H Ang OH H Glc-p 
34 Escin V H MP Ac OH H Glc-p 
35 Escin VI H MB Ac OH H Glc-p 
36 Escin VIb Ang Ac H OH H Glc-p 
37 Deacetylescin Ia H Tig H OH H Glc-p 
38 Deacetylescin Ib H Ang H OH H Glc-p 
39 Deacetylescin IIa H Tig H OH H Xyl-p 
40 Deacetylescin IIb H Ang H OH H Xyl-p 
41 Desacylescin I H H H OH H Glc-p 
42 Desacylescin II H H H OH H Xyl-p 
43 Isoescin Ia H Tig H OH Ac Glc-p 
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Compound 21-62. contd…. 
No. Name R1 R2 R3 R4 R5 R6 
44 Isoescin Ib H Ang H OH Ac Glc-p 
45 Isoescin IIa H Tig H OH Ac Xyl-p 
46 Isoescin IIb H Ang H OH Ac Xyl-p 
47 Isoescin IIIa H Tig H H Ac Gal-p 
48 Isoescin IIIb H Ang H H Ac Gal-p 
49 Isoescin V H MP H OH Ac Glc-p 
50 Isoescin VIa H MB H OH Ac Glc-p 
51 Isoescin VIIa H Tig H OH Ac Gal-p 
52 Isoescin VIIIa H Ang H H Ac Glc-p 
53 Aesculioside A H Tig H OH H Glc-p 
54 Aesculioside B H Ang H OH H Glc-p 
55 Aesculioside C H Tig Tig OH H Glc-p 
56 Aesculioside D H Tig Ang OH H Glc-p 
57  H Ang Ang OH H Glc-p 
58 Aesculiside A H Ac H OH Ac Glc-p 
59 Aesculuside B H H H OH H Glc-p 
60 Assamicin III H 4-O-ang-6-deoxy-glc-p H OH Ac Glc-p 
61 Assamicin IV H 4-O-ang-6-deoxy-glc-p H OH H Glc-p 
62 Assamicin VI H 3,4-O-diang-6-deoxy-glc-p H OH Ac Glc-p 
 
traditional Chinese medicines, have the same medicinal value 
[11]. A number of saponins including escins Ia (21) [52], Ib 
(22) [52], IVc (28) [52], IVd (29) [52], IVe (30) [53], IVh 
(33) [53], aesculuside A (deacetylescin Ib, 38) [53], 
isoescins Ia (43) [52] and Ib (44) [52] were isolated and 
identified from the seeds of this variety.  Except aesculuside 
A (38), all saponins isolated from A. chinensis var. chekian-
gensis were also found in the seeds of A. chinensis var. 
chinensis. 
The saponins from other species of the section Calothyr-
sus were also reported.  Interestingly, some unique saponins 
including assamicins I (67) [54], II (68) [54], III (60) [55], 
IV (61) [55], V (69) [56], VI (62) [57], VII (70) [57], and 
VIII (71) [57] were isolated and identified from A. assamica, 
together with a known saponin isoescin Ib (44).  In addition, 
aesculusides A (deacetylescin Ib, 38) [58], B (59) [59], and 
3-O-[β-D-glucopyranosyl-(1→2)]-[β-D-glucopyranosyl-
(1→4)]-β-D-glucuronopyranosyl-21,22-O-diangeloyl-
3β,16α,21β,22α,24β,28-heptahydroxyolean-12-ene (57) [56] 
were isolated from A. indica.   
The investigation of saponins from section Pavia is lim-
ited to A. pavia. Recently, a detailed phytochemical investi-
gation of the saponins occurring as a very complex mixture 
from the fruits of A. pavia located in Nacogdoches (Texas, 
USA) resulted in the isolation and discovery of 25 new 
saponins, named as aesculiosides Ia–Ie (72-76), IIa–IIk (77-
87), IIIa–IIIf (88-93), and IVa–IVc (95, 97, 99), together 
with three known saponins 3-O-[β-D-galactopyranosyl-
(1→2)]-[α-L-arabinofuranosyl-(1→3)]-β-D-glucuronopyra- 
nosyl-21,22-O-diangeloyl-3β,15α,16α,21β,22α, 28-hexahy- 
droxyolean-12-ene (xanifolia-Y, 94), 3-O-[β-D-glucopyr- 
anosyl-(1→2)]-[α-L-arabinofuranosyl-(1→3)]-β-D-glucuro- 
nopyranosyl-21,22-O-diangeloyl-3β,16α,21β,22α,24β,28-
hexahydroxyolean-12-ene (96), and 3-O-[β-D-galacto- 
pyranosyl-(1→2)]-[a-L-arabinofuranosyl-(1→3)]-β-D-gluc- 
uronopyranosyl-21,22-O-diangeloyl-3β,16α,21β,22α,28-
pentahydroxyolean-12-ene (98) [16, 61].  
The polyhydroxylated triterpenoid saponins from the ge-
nus Aesculus share a common oligosaccharide chain with a 
glucuronopyranosyl unit attached to C-3 of the aglycone, 
although the components and sequences of the oligosaccha-
rides are different, Interestingly the type of the monosaccha-
ride linked to C-2 of the glucuronopyranosyl unit in the oli-
gosaccharide chain for the most of saponins (21-50, 53-68) is 
related to the substituent at C-24 of aglycone. Specifically, 
the saponins possessed the aglycones of 24-hydroxy-R1-
barrigenol (3) or protoaescigenin (5) with a hydroxyl group 
at C-24 had a glucopyranosyl or xylopyranosyl unit attached 
to C-2 of the glucuronopyranosyl unit while a galac-
topyranosyl unit linked to C-2 of the glucuronopyranosyl 
unit was found in the saponins with the aglycones of R1-
barrigenol (4) or barringtogenol-C (6) without the hydroxyl 
group at C-24. Isoescins VIIa (51), VIIIa (52), and assamicin 
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No. Name R1 R2 R3 R4 
67 Assamicin I Ang Ac Glc-p Rha-p 
68 Assamicin II 3,4-O-diangeloyl-6-deoxy-glc-p Ac D-Glc-p Rha-p 
69 Assamicin V Ang H H Rha-p 
70 Assamicin VII Ang H Rha-p Glc-p 
71 Assamicin VIII Ang H H Glc-p 
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Compounds 72-99. contd…. 
No. Name R1 R2 R3 R4 R5 R6 
72 Aesculioside Ia OH H H H H Gal-p 
73 Aesculioside Ib OH H H OH H Glc-p 
74 Aesculioside Ic H H H H H Gal-p 
75 Aesculioside Id H H H OH H Glc-p 
76 Aesculioside Ie H H H OH H H 
77 Aesculioside IIa OH Ang H H H Gal-p 
78 Aesculioside IIb H Ang H OH H Glc-p 
79 Aesculioside IIc H Ang H H H Gal-p 
80 Aesculioside IId H Ang H OH H H 
81 Aesculioside IIe OH Tig Ac OH H Glc-p 
82 Aesculioside IIf OH Tig Ac H H Gal-p 
83 Aesculioside IIg OH Ang Ac H H Gal-p 
84 Aesculioside IIh H Tig Ac OH H Glc-p 
85 Aesculioside IIi H Ang Ac OH H Glc-p 
86 Aesculioside IIj H Tig Ac H H Gal-p 
87 Aesculioside IIk H Ang Ac H H Gal-p 
88 Aesculioside IIIa H Ang H OH Ac Glc-p 
89 Aesculioside IIIb OH Ang MP OH H Glc-p 
90 Aesculioside IIIc OH Tig MP H H Gal-p 
91 Aesculioside IIId OH Tig Tig OH H Glc-p 
92 Aesculioside IIIe OH Tig Ang OH H Glc-p 
93 Aesculioside IIIf OH Tig Tig H H Gal-p 
94 Xanifolia-Y OH Ang Ang H H Gal-p 
95 Aesculioside IVa OH Ang MB H H Gal-p 
96  H Ang Ang OH H Glc-p 
97 Aesculioside IVb H Ang MB OH H Glc-p 
98  H Ang Ang H H Gal-p 
99 Aesculioside IVc H Ang MB H H Gal-p 
 
VII (70) are the only three saponins that exhibit exceptions 
to this structural configuration.  
The saponins from the five Eurasian taxa, including A. 
hippocastanum, A. chinensis var. chinensis, A. chinensis var. 
wilsonii, A. turbinata, and A. indica discussed above (Table 
2), were structurally based on two aglycones of protoaesci-
genin (5) and barringtogenol-C (6) with a trisaccharide chain 
at C-3 position of the aglycone. This trisaccharide chain has 
a glucopyranosyl unit attached to C-4 of the glucurono-
pyranosyl unit, which is linked to C-3 of the aglycone. The 
aglycones of the saponins from the North America species A. 
pavia are more variable with four different aglycones, in-
cluding 24-hydroxy-R1-barrigenol (3), R1-barrigenol-C (4), 
protoaescigenin (5) and barringtogenol-C (6). These sapon-
ins (72-99) from A. pavia have an oligosaccharide chain at 
C-3 of the aglycone with an arabinofuranosyl unit affixed to 
C-3 of the glucuronopyranosyl unit instead. This significant 
chemical difference represents a variable chemotaxonomic 
feature and may be the basis for different medicinal uses 
between North American and Eurasian Aesculus species. 
This result also supports a conclusion drawn from pheno-
typic and DNA sequence analyses that eastern North Ameri-
can species of Aesculus represent a different evolutionary 
lineage that diverged early from their Eurasian counterparts 
[1, 4, 13]. 
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It is also worth mentioning that assamicins I (67), II (68), 
III (60), IV (61), V (69), VI (62), VII (70), and VIII (71) 
from A. assamica have different components and sequences 
of the oligosaccharide chain at C-3 from the saponins iso-
lated from the other Aesculus species. Some of assamicin 
saponins (60, 61, 62, and 68) have two oligosaccharide 
moieties attached to C-3 and C-21 of the aglycone. 
Flavonoids 
Flavonoids and their derivatives are also one of the main 
components of the genus Aesculus. A total of 49 flavonoids 
including flavonols and their glycosides (100-126), 
flavanones, and flavanone derivatives (127-148) were iso-
lated and identified from the seeds of Aesculus. The gly-
cosides of quercetin (100) and kaempferal (116) with an oli-
gosaccharide chain at C-3 or two oligosaccharide chains at 
C-3 and C-3' are types of flavonol glycosides while 
flavanone derivatives are characterized as one of two types 
of proanthocyanidin and polymerized epicatechin.  
A few early investigations led to the isolation and identi-
fication of rutin (111), quercitrin (113), and astragalin (122) 
from A. indica [62, 63] and quercetin (100) and kaempferal 
(116) from A. assamica [33]. 
The flavonols and their glycosides from the seeds of A. 
hippocastanum have been well documented. Two investiga-
tions on the seeds of this species resulted in the isolation and 
structural determination of 15 flavonols and their glycosides 
[64, 65]. These compounds are quercetin 3-O-[β-D-xylopyr- 
anosyl-(1→2)]-[O-β-D-glucopyranosyl-(1→3)]-O-β-D-glu- 
copyranosyl-3′-O-β-D-glucopyranoside (101), tamarixetin 3-
O-[β-D-xylopyranosyl-(1→2)]-[O-β-D-glucopyranosyl-
(1→3)]-O-β-D-glucopyranosyl-3′-O-β-D-glucopyranoside 
(102), quercetin 3-O-β-D-xylopyranosyl-(1→2)-O-β-D-
glucopyranosyl-3′-O-β-D-glucopyranoside (104), quercetin 
3-O-[β-D-xylopyranosyl-(1→2)]-[O-β-D-glucopyranosyl-
(1→3)]-O-β-D-glucopyranoside (106), quercetin 3-O-β-D-
xylopyranosyl-(1→2)-O-β-D-glucopyranosyl-(1→3)-O-β-D-
glucopyranoside (107), tamarixetin 3-O-[β-D-xylopyranosyl-
(1→2)]-[O-β-D-glucopyranosyl-(1→3)]-O-β-D-glucopyran- 
oside (108), quercetin 3-O-β-D-xylopyranosyl-(1→2)-O-β-
D-glucopyranoside (109), quercetin 3-O-β-D-xylopyranosyl-
(1→4)-O-α-L-rhamnopyranoside (multinoside A, 110), 
quercetin 3-O-β-D-xylopyranosyl-(1→2)-O-β-D-glucopyra- 
nosyl-3′-O-[nicotynoyl-(1→6)]-β-D-glucopyranoside (124), 
quercetin 3-O-β-D-xylopyranosyl-(1→2)-O-β-D-glucopyr- 
anosyl-3′-O-[indolin-2-on-3-hydroxy-3-acetyl-(1→6)]-β-D-
glucopyranoside (125), quercetin 3-O-β-D-xylopyranosyl-
(1→2)-O-β-D-glucopyranosyl-3′-O-[indolin-2-on-3-acetyl-
(1→6)]-β-D-glucopyranoside (126), kaempferal 3-O-[β-D-
xylopyranosyl-(1→2)]-[O-β-D-glucopyranosyl-(1→3)]-O-β-
D-glucopyranoside (118),  kaempferal 3-O-β-D-xylopyran- 
osyl-(1→2)-O-β-D-glucopyranosyl-(1→3)-O-β-D-glucopyr- 
anoside (119), kaempferal 3-O-β-D-xylopyranosyl-(1→2)-
O-β-D-glucopyranoside (leucoside, 120),  and kaempferal 3-
O-β-D-xylopyranosyl-(1→4)-O-α-L-rhamnopyranoside(mul- 
tiflorine B, 121).  
The seeds of A. chinensis var. chinensis are rich in fla-
vonoids. A number of flavonoid glycosides were isolated 
from the seeds of this species. These flavonoids were identi-
fied as quercetin 3-O-[β-D-xylopyranosyl-(1→2)]-[α-L-
rhamnopyranosyl-(1→6)]-β-D-glucopyranosyl-3′-β-D-glu- 
copyranoside (aescuflavoside, 103), quercetin 3-O-β-D-
xylopyranosyl-(1→2)-β-D-glucopyranosyl-3′-β-D-glucopy- 
ranoside (104), tamarixetin 3-O-β-D-xylopyranosyl-(1→2)-
β-D-glucopyranosyl-3′-O-β-D-glucopyranoside (aescufla-
voside A, 105), quercetin 3-O-β-D-xylopyranosyl-(1→2)-β-
D-glucopyranoside (109), quercetin 3-O-β-D-glucopyranoside 
(isoquercitrin, 112), kaempferal 3-O-[β-D-xylopyranosyl-
(1→2)]-[β-D-glucopyranosyl-(1→6)]-β-D-glucopyranoside 
(117), kaempferal 3-O-β-D-xylopyranosyl-(1→2)-β-D-
glucopyranoside (leucoside, 120), kaempferal 3-O-β-D-
glucopyranosyl-(1→4)-α-L-rhamnopyranoside (multiflorine 
B, 121), kaempferal-3-O-β-D-glucopyranoside (astragalin, 
122), and kaempferal-3-O-β-D-galactopyranoside (trifolin, 
123) [66]. 
Three known flavonoid glycosides quercetin 3-O-α-L-
rhamnopyranoside (quercitrin, 113), quercetin 3-O- α-L-
arabinopyranoside (114), and isorhamnetin 3-O-α-L-
arabinoside (distichin, 115) were recently isolated and identi-
fied from the leaves of A. pavia, grown in Italy [67].  
In addition, some flavanone derivatives were also identi-
fied from Aesculus species. These compounds include (−)-
epicatechin (127) from the seeds of A. californica [68]; 
proanthocyanidins A-2 (131), A-4 (132), A-6 (134), A-7 
(135), B-2 (130), B-5 (133), C-1 (137), epicatechin-(4β→6)-
epicatechin-(4β→6)-epicatechin (139), cinnamtannins B1 
(136), B2 (138), aesculitannins A (140), B (141), C (142), D 
(143), E (144), F (145),G (146) [69], and leucocyanidine 
(128) [70] from the seeds of A. hippocastanum; and three 
docyl sulfide derivatives of (−)-epicatechin (129) and proan-
thocyanidins (147, 148) from the seeds of A. turbinata [19]. 
Coumarins 
Coumarins isolated from Aesculus usually have simple 
structures. The main coumarins are esculetin (150), fraxetin 
(151), fraxin (156), and aesculin (157) from A. turbinata [71, 
72]; umbelliferone (149), esculetin (150), scopoletin (152), 
isoscopoletin (153), skimin (154), chikhorin (155), fraxin 
(156), aesculin (157), scopolin (158), and isoscopolin (159) 
from A. hippocastanum [73]; and scopolin (158) and 5-
methoxyscopolin (160) from A. pavia [61]. Recently, a new 
prenylated coumarin with antifungal activity, pavietin (161), 
was isolated and identified from the leaves of A. pavia [67]. 
Carotenoids 
Twenty-one carotenoids have been identified from Aes-
culus. An early investigation on the leaves and pollen of the 
three species A. turbinata, A. pavia, and A. parviflora by 
HPLC analysis indicated the presence of seven carotenoids 
β-carotene (162), zeaxanthin (163), α-carotene (167), lutein 
(168), capsanthin (176), capsanthin 5,6-epoxide (177), and 
capsorubin (178) [74]. A high concentration of α-carotene 
was found in the leaves and keto hydroxyl carotenoids with a 
pentanuclear ring structure (capsanthin, capsanthin 5,6-
epoxide, and capsorubin) were identified in the pollen. These 
keto hydroxyl carotenoids were proposed to have special 
chemotaxonomic significance for the genus Aesculus. Later, 
in 2000, 16 carotene derivatives were detected in buds, pol-
len, and petals of A. hippocastanum and A. pavia by HPLC 
analysis with a diode array detector utilizing authentic sam-
ples as the references. These carotenoids are β-carotene 
(162), β-cryptoxanthin (164), violaxanthin (165), 9-cis-
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149 Umbelliferone H H H H 
150 Esculetin H OH H H 
151 Fraxetin H OCH3 H OH 
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violaxanthin (166), lutein (168), 13-cis-13'-cis-lutein (169), 
lutein 5, 6-epoxide (170), neolutein C (171), β-citraurin (172), 
aesculaxanthin (173), 9-cis-aesculaxanthin (174), 13-cis-aes- 
culaxanthin (175), 9'-cis-neoxanthin (179), 9-cis-9'-cis-neox- 
anthin (180), neochrome (181), and luteoxanthin (182) [75]. 
Long Fatty Chain Compounds 
The seeds of Aesculus also contain a number of long fatty 
chain compounds. These compounds include lauric acid 
(183), myristic acid (184), palmitic acid (185), stearic acid 
(189), arachic acid (190), and oleic acid (191) from A. hip-
pocastanum and A. indica [76]; linoleic acid (192) from A. 
hippocastanum [70]; oleic acid (191), linoleic acid (192), 
and linolenic acid (193) from the seeds of A. turbinata [20]; 
heptadecanoic acid (186), methyl heptadecanoate (187), 
ethyl heptadecanoate (188), methyl octadec-(13Z)-enoate 
(194), ethyl octadec-(13Z)-enoate (195) [77], palmitone 
(197), n-hentriacontanol (198), and n-hentriacontane (199) 
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from A. indica [78]; and tianshic acid (196) from A. chinen-
sis var. wilsonii [79]. 
Other Compounds 
Some other classes of components were isolated and 
identified from some species of Aesculus. These compounds 
are ester of indole-3-acetic acid and myo-inositol (200), ester 
of indole-3-acetic acid and the disaccharide rutinose (201), 
three cyclopropane amino acids of cis-α-(carboxycyclo- 
propyl)-glycine (202), trans-α-(carboxycyclopropyl)-glycine 
(203), and exo-3,4-methanoproline (204) from A. parviflora  
[80, 81]; 2-amino-4-methylhexanoic acid (205), 2-amino-4-
methylhex-4-enoic acid (206), N-(1-carboxy-3-methyl-3-
pentenyl-glutamine (207), α-amino-β-methyl-2-methylene-
cyclopropanepropionic acid (208), 2-amino-6-hydroxy-4-
methylhex-4-enoic acid (209), and arbutin (210) from A. 
californica [68, 82]; and wilsonic acid (211), N-acetyl glu-
tamic acid (212), and fumaric acid (213) from A. chinensis 
var. wilsonii [79, 83]. 
BIOLOGICAL AND PHARMACOLOGICAL ACTIVI-
TIES 
Anti-inflammatory Activities 
The therapeutic benefits of HCSE and aescin for the 
treatment of chronic venous insufficiency, hemorrhoids, and 
postoperative edema are due to their significant anti-
inflammatory properties, which were demonstrated in animal 
models [5, 50, 84, 85]. The anti-inflammatory activities of 
HCSE or aescin are related to the molecular mechanism of 
the agents, which include the improved entry of ions into 
channels [86] thus raising venous tension [87], the release of 
prostaglandin-F2a from veins [88], the release of inflamma-
tory mediators by decreasing leukocyte activation and adhe-
siveness [84, 89], the antagonism to the pro-inflammatory 5-
HT receptors and histamine [90], and the decrease in the 
activity of tissue hyaluronidase [91].  
Individual compounds isolated and identified from the 
genus Aesculus also showed anti-inflammatory properties. 
Escins Ia (21), Ib (22), IIa (23), and IIb (24) from A. hippo-
castanum prevented the increase of vascular permeability 
induced by both acetic acid in mice and histamine in acute 
inflammatory rats. Escins Ia, Ib, IIa, and IIb inhibited hind 
paw edema induced by carrageenin and scratching behavior 
in mice. However, desacylescins I (41) and II (42) without 
acyl groups had no effects in the animal model tested, which 
suggests that acyl groups in escins were essential for their 
activities [92]. Escins Ia, Ib, isoescins Ia (43), and Ib (44) 
isolated from the seeds of A. chinensis var. chinensis mark-
edly inhibited dimethyl benzene induced inflammation in 
mice at a dose of 30 mg/kg. The inhibitory effects of the four 
pure saponins were nearly equal to each other, but had more 
potent activity than a total saponin extract and dexametha-
sone, a commercially available anti-inflammatory drug [50]. 
Oleic acid (191), linoleic acid (192), and linolenic acid (193) 
from a hexane seed extract of A. turbinata showed an inhibi-
tion of the activity of cyclooxygenase (COX-1 and COX-2), 
the important target for anti-inflammatory drugs. Linolenic 
acid and linoleic acid had a high selectivity toward COX-2 
[20]. 
Anti-tumor Activities 
Recent studies in vivo and in vitro indicate that aescin (β-
escin) has significant antitumor activities. β-escin from A. 
hippocastanum inhibited chemically induced colon carcino-
genesis in rats, and in vitro exhibited cytotoxicity at 30 
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µmol/L or above concentrations in colon cancer cell lines. β-
Escin at 5 µmol/L also inhibited HT-29 colon cancer cell 
proliferation. β-escin induced cell cycle arrest at G1-S phase 
in part mediated by induction of p21WAF1/CIP1 and/or as-
sociated with reduced levels of Cdk2 and cyclins A and E 
complex; additionally, there was a lower phosphorylation of 
Rb [93]. 
β-escin isolated from the seeds of A. chinensis var. 
chinensis induced apoptosis and caused a significant inhibi-
tion of HL-60 human acute myeloid leukemia cell and K562-
huamn chronic myeloid leukemia cell proliferation in dose- 
and time-dependent fasion. Morphological evidence of apop-
tosis, a significant increase of annexin V+ and PI- cells 
(early apoptotic) and apoptotic DNA fragmentation, were 
observed in K562 cells treated with β-escin. Flow cytometry 
analysis indicated that β-escin induced G1-S arrest and led to 
a significant accumulation of the sub-G1 population in HL-
60 and K562 cells [94, 95].  
Aescin isolated from the seeds of A. chinensis var. wil-
sonii at a dose of 2.8 mg/kg had a rather high inhibition ratio 
(43.5 %) on mice H22 tumor growth in vivo. Aescin could 
induce significant concentration- and time-dependent inhibi-
tion of HepG (2) cell viability and induce cell cycle check-
point arrest and caspase-independent cell death in HepG (2) 
cells [96].  
An early investigation showed that two prosapogenins of 
21-O-tigloyl-22-O-angeloyl-R1-barrigenol (10) and 21-O-
angeloylbarringtogenol-C (18) from the acid hydrolysates of 
the HCSE of A. hippocastanum exhibited significant in vitro 
cytotoxicity with ED50 of 3.6 µg/mL and 3.0 µg/mL, respec-
tively, in the human nasopharyngeal carcinoma 9-KB cell 
culture assay [27]. 
More recently, 28 individual saponins (72-99) from the 
fruits of A. pavia and six prosapogenins produced from these 
saponins were assayed in vitro for their cytotoxicity and in-
hibition of DNA topoisomerase I (TOP1) [61, 97]. Saponins 
94, 96 and 98 with two acyl groups at C-21 and C-22 
showed activity with GI50 of 0.175–8.71 µM against most of 
59 cell lines tested, which were from nine different human 
cancers including leukemia, non-small cell lung, colon, cen-
tral nervous system (CNS), melanoma, ovarian, renal, pros-
tate, and breast tumor cell lines. Aesculiosides IIc (79) and 
IId (80) with only one acyl group at C-21 showed less activ-
ity while aesculiosides Ia-e (72-76) without acyl group 
showed no or weak activity [61]. Aesculiosides IIa-k (77-
87), IIIa-f (88-93), IVa (95), IVb (97), IVc (99), saponins 94, 
96, 98 and six prosapogenins were also tested for their inhi-
bition of DNA topoisomerase I (TOP1) and their activities 
against A549, PC-3, HL-60, PANC-1, and MRC cell lines. 
Most of the tested saponins and prosapogenins with acyl 
groups showed cytotoxic activity with different GI50 value. 
Sixteen cytotoxic aesculiosides 77-80 and 88-99 inhibited 
TOP1 catalytic activity by interacting directly with the free 
enzyme and preventing the formation of the DNA-TOP1 
complex. Interestingly, six prosapogenins, including 21-O-
angeloylproaescigin (13), 21,22-O-diangeloylprotoaescigenin 
(16), 21,22-O-diangeloylbarringtogenol-C (20), 21-O-angel- 
yol-22-O-2-methylbutanoyl-R1-barrigenol, 21-O-angelyol-
22-O-2-methylbutanoylprotoaescigenin, and 21-O-angelyol-
22-O-2-methylbutanoylbarringtogenol-C prepared from the 
acid hydrolysates of saponins 78, 96, 98, 95, 97, and 99, 
respectively, showed no TOP1 inhibitory activity, but had 
stronger cytotoxicity when compared to the related saponins 
[97]. 
Antiviral and Antifungal Activities 
Isoescins Ia (43) and Ib (44) and escins Ia (21), Ib (22), 
IVc (28), IVd (29), IVe (30), and IVf (31) isolated from the 
seeds of A. chinensis var. chinensis showed activity against 
HIV-1 protease. Escins Ia (21) and Ib (22) inhibited the en-
zyme’s activity by 86.1 ± 0.2% at 100 µM with IC50 values 
of 35 and 50 µM, respectively, while saponins 28-31, 43, and 
44 showed weaker antiviral activity [47].  
Three flavonol glycosides of aescuflavoside (103), aescu-
flavoside A (105), and leucoside (120) from A. chinensis var. 
chinensis showed significant antiviral activities against respi-
ratory syncytial virus with IC50 values of 4.5, 6.7, and 4.1 
µg/mL, and selective index values of 15.8, 32, and 63.8, re-
spectively. Astragalin (122) demonstrated significant antivi-
ral activity against influenza virus type A with an IC50 of 
24.5 µg/mL and a selective index of 16.0 [66]. 
Pavietin (161), a new prenylated coumarin, isolated from 
the leaves of a genotype of A. pavia, showed antifungal ac-
tivity. In a preliminary antifungal screening by filter disk 
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method, pavietin (15 mg/dish) possessed significant activity 
against an Aesculus-specific fungal parasite, Guignardia 
aesculi, and weaker activity against the generalist poly-
phagous Pythium ultimum and the Aesculus nonpathogenic 
Fusarium basilici. More detailed antifungal screening by 
adding pavietin to mycelial growth medium of different fun-
gal pathogens showed that pavietin exhibits appreciable an-
timicrobial properties against several pathogens including 
Alternaria alternata, A. dianthi, Aspergillus niger, Botrytis 
cinerea, Cladosporium fulvum, Fusarium oxysporum dianthi, 
Guignardia aesculi, Penicillium expansum, Polyporus mar-
ginatus, Rhizopus stolonifer, and Trichoderma viride [67]. 
Antiangiogenic Activities (Vascular Protection) 
β-escin sodium inhibited angiogenesis in chick chorioal-
lantoic membrane [98] and in aortic disk assay [99]. Further 
study indicated that β-escin sodium (10, 20, and 40 µg/mL) 
dose-dependently inhibited endothelial cells (ECs) prolifera-
tion in human umbilical vein endothelial cells and ECV304 
cells. β-escin sodium also induced ECs apoptosis at 40 
µg/mL and suppressed ECs migration and cell motility. 
Western blot results suggest that β-escin sodium acts on ECs 
possibly by increasing expression of thrombospondin-1, de-
creasing expression of PKC-α and activation of p44/42 mi-
togen-activated protein (MAP) kinase and p38 mitogen-
activated protein kinase (p38 MAPK) [100]. 
Aescin from A. hippocastanum was found to improve en-
dothelial dysfunction in rat aortic rings subjected to oxida-
tive stress generated by pyrogallol and to induce contraction 
in these preparations. These apparently contradicting effects 
could be due to the well-known ability of escin to enhance 
cellular permeability to calcium which, on one hand, would 
increase endothelial nitric-oxide synthase (eNOS) activity 
and nitric oxide production and would lead to vascular 
smooth muscle contraction. Endothelial protection could 
contribute to the therapeutic usefulness of escin, while arte-
rial vasoconstriction could represent a limiting side effect in 
susceptible patients [101]. 
When HUVECs (human vascular endothelial cells) were 
exposed to CoCl2 as an in vitro model of hypoxia, aescin 
from A. hippocastanum, in a dose-dependent fashion (0.1-1.0 
µM), prevented the action of CoCl2 on the vascular cell ad-
hesion molecule (VCAM-1) and platelet endothelial cell 
adhesion molecule (PECAM-1) and preserved endothelial 
cell morphology. In an in vitro model of inflammation in-
duced by Escherichia coli lipopolysaccaride (LPS), aescin 
reduced IL-6 release from LPS-activated vascular endothe-
lium [102]. 
HCSE from A. hippocastanum dose-dependently con-
tracted both bovine mesenteric veins and arteries, with veins 
being the more sensitive. Contraction of both veins and arter-
ies was significantly inhibited by the 5-HT(2A) receptor an-
tagonist ketanserin. HCSE also significantly reduced ADP-
induced human platelet aggregation. These findings may, at 
least partly, account for the mechanism of action of HCSE in 
the treatment of chronic venous insufficiency [103]. 
Anti-obesity Effects 
Escins Ia (21), Ib (22), IIa (23), IIb (24), deacetylescins 
Ia (37), Ib (38), IIa (39), IIb (40), and desacylescins I (41) 
and II (42) had inhibitory effects on the elevation of blood 
glucose levels by means of the oral glucose tolerance test in 
mice. Escins (21-24) with two acyl groups had stronger ac-
tivity than deacetylescins (37-40) with only one acyl group 
and desacylescins (41, 42) without acyl group [38, 39, 43]. 
These compounds also exhibited the activity of pancreatic 
lipase with very different IC50 values. Escins (21-24) had 
low IC50 values of 14−61 µg/mL, while deacetylescins Ia and 
IIa had very high IC50 values of 345, and >400 µg/mL, re-
spectively [43]. Escins (21-24) with two acyl groups at C-21 
and C-22 showed potent inhibitory activity on ethanol ab-
sorption in the dose of 50-100 mg/kg [38, 39]. An analysis 
comparing the structure and activity suggested that the acyl 
groups at C-21 and C-22 in these saponins were important 
for their activities.  
Testing by using 4-methylumbelliferyl oleate as a sub-
strate, escins (21-24), deacetylescins (37-40), and desa-
cylescins (41, 42) isolated from the natural and edible seeds 
of A. turbinata exhibited inhibitory effect on lipase activity. 
The potency was in the order of escins > desacylescins > 
deacetylescins. Escins Ib and IIb as well as deacetylescins Ib 
and IIb with the angeloyl moiety were more potent than the 
corresponding Ia and IIa series with the tigloyl moiety. 
Saponin fractions from natural seeds (SFNS) and edible 
seeds (SFES) of A. turbinata effectively inhibited fat diges-
tion in an in vivo anti-obesity experiment in mice fed high-
fat diets. SFNS (0.1% or 0.5%) and SFES (0.5%) both sig-
nificantly attenuated the elevation in body weight, the mass 
of peritoneal adipose tissues, and plasma triacylglycerol, 
which was accompanied by higher contents of undigested 
fats in feces without changes in food intake [104]. Escins Ib 
and IIa also inhibited pancreatic lipase activity with dose-
dependence (0-0.5 mg/mL) in an in vitro assay system using 
triolein emulsified with lecithin [105].  
In addition, assamicins I (67, 100 µg/mL) and II (68, 25 
µg/mL) almost completely inhibited release of free fatty ac-
ids from epinephrine-treated rat adipocytes. Both compounds 
enhanced glucose uptake into 3T3-L1 adipocytes as insulin 
does. When the cells were incubated in a medium containing 
[3H]-2-deoxyglucose, the uptake of the radioisotope into the 
cells was enhanced 2.5- and 3.5-fold by addition of assami-
cins I and II, respectively, at the concentration of 25 µg/mL. 
Assamicin II showed stronger activity than assamicin I in 
both assay systems tested [57]. 
Antioxidant and Antigenotoxic Activities 
HCSE from the seeds of A. turbinata dose-dependently 
inhibited the autooxidation of linoleic acid (IC50 of 0.2 
mg/mL) and the inhibition was almost complete at a concen-
tration of 1 mg/mL. The HCSE scavenged DPPH radicals 
and superoxide anions with IC50 of 0.65 and 0.21 mg/mL, 
respectively. The polyphenols (21 mg/g) in the HCSE were 
the main active compounds [106]. This HCSE also inhibited 
the genotoxicities induced by furylfuramide, N-methyl-N-
nitrosourea, methyl methanesulfonate, mitomycin C, 2-
aminoanthracene and aflatoxin B1 at a concentration of 1 
mg/mL or more [106].  
Aescin from the seeds of A. hippocastanum increased the 
antioxidative defense system of the body and prevented high 
fat diet (HFD)-induced lipid peroxidation in male mice fed 
either standard pellet diet (SPD) or HFD at 100mg/kg doses 
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daily for 5 weeks. Aescin mixture prohibited the adverse 
effects of oxidative stress and showed a protective effect on 
the liver architecture both in SPD and HFD consumed male 
mice. Combined administration of high-fat diet with escin 
mixture significantly increased blood and liver reduced glu-
tathione GSH levels in mice and decreased the level of 
malondialdehyde in blood, liver, kidney, heart, the level of 
liver superoxide dismutase, and the catalase activity [107]. 
Three docyl sulfide derivatives of (−)-epicatechin (129) 
and proanthocyanidins (147, 148) isolated from the seeds of 
A. turbinata showed potent antioxidative activity by assaying 
with DPPH (1,1-diphenyl-2-picrylhydrazyl). Compounds 
147 and 148 exhibited similar antioxidative activities with 
IC50 of 2.4−2.6 µg/mL. Their inhibitory actions were slightly 
more potent than that of the monomer of (−)-epicatechin or 
(+)-catechin [19]. 
CONCLUSIONS 
The genus Aesculus has 12 species, but only A. hippocas-
tanum and A. chinensis var. chinensis, two Eurasian species, 
are officially recognized sources of herbal products in tradi-
tional medicine. HCSE or aescin from A. hippocastanum has 
shown satisfactory evidence for clinically significant activity 
in chronic venous insufficiency, hemorrhoids, and post-
operative oedema, largely due to its anti-inflammatory prop-
erties, which were well demonstrated by in vitro and in vivo 
assay. However, the mechanism of action of the Chinese 
horse chestnut is poorly understood and further investigation 
is necessary.   
Although other constituents may have some bioactivity, 
the polyhydroxylated triterpenoid glycosides (saponins) in 
Aesculus extract are considered to be the major active princi-
ples. To date, the saponins from the seeds of six species in-
cluding A. hippocastanum (AH), A. chinensis var. chinensis 
(ACC), A. chinensis var. wilsonii (ACW), A. turbinata (AT), 
A. assamica (AA), and A. pavia (AP) have been well docu-
mented. Very interestingly, the saponins from four Eurasian 
species (AH, ACC, ACW, and AT) have very similar struc-
tures but are different from the novel cytotoxic saponins 
from an eastern North American species A. pavia. This 
chemical difference suggests a chemotaxonomic significance 
between the two groups [13, 61].   More studies of the 
saponins from the seeds of other North American species are 
necessary to further confirm the chemotaxonomic value of 
these novel cytotoxic saponins.  Detailed investigations on 
the saponins from the seeds of other Aesculus species, which 
have not been conducted phytochemically, are also needed to 
fully understand the chemical profile of the genus Aesculus. 
These studies, which are now being conducted at Stephen F. 
Austin State University, may not only identify more bioac-
tive saponins but could also provide chemotaxonomic data 
for the genus Aesculus and better understanding of its evolu-
tion. 
The biological and pharmacological activities of HCSE, 
aescin, and individual components from the genus Aesculus 
have received much interest in recent years. Accumulated 
studies indicate that HCSE, aescin, and individual com-
pounds have anti-inflammatory, antitumor, antiviral, anti-
fungal, antiangiogenic (vascular protection), anti-obesity 
antioxidative, and antigenotoxic properties. One of the most 
interesting activities is the antitumor property of some novel 
saponins discovered recently from A. pavia. This type of 
novel saponins has showed potent cytotoxicity and inhibition 
of TOP1 by in vitro assays [61, 97, 108]. Further animal 
studies are required to evaluate the potential for the treatment 
of cancer as anticancer agents. 
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ABBREVIATIONS 
A549 = Human lung adenocarcinoma epithelial 
cell line 
Ac = Acetyl 
Ang = Angeloyl 
CNS = Central nervous system 
COX = Cyclooxygenase  
DPPH = 1,1-diphenyl-2-picrylhydrazyl 
EC = Inhibited endothelial cell  
eNOS = Endothelial nitric-oxide synthase 
HCSE = Horse chestnut seed extract 
HFD = High fat diet 
HL-60 = Human promyelocytic leukemia cell 
line 
HUVEC = Human vascular endothelial cell 
LPS = Lipopolysaccaride  
MAP = Mitogen-activated protein  
MB = 2-methylbutanoyl 
MP = 2-methylpropanoyl 
MARC-5 = Human normal lung cell line 
p38 MAPK = p38 mitogen-activated protein kinase 
PANC-1 = Human pancreatic carcinoma, epithe-
lial-like cell line 
PECAM-1 = Platelet endothelial cell adhesion mole-
cule 
SFES = Saponin fractions from edible seed 
SFNS = Saponin fractions from natural seed 
SPD = Standard pellet diet 
STE = Standardized therapeutic extract 
Tig = Tigloyl 
TOP1 = DNA topoisomerase I 
VCAM-1 = Vascular cell adhesion molecule 
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